|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-19
|
|
pubmed:abstractText |
Patients treated with aspirin may have a reduced sensitivity to its antiplatelet effect. The mechanism accounting for such a reduced sensitivity might involve an impaired interaction of aspirin with cyclooxygenase-1 (COX)-1.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2784-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16359516-Aged,
pubmed-meshheading:16359516-Aspirin,
pubmed-meshheading:16359516-Blood Platelets,
pubmed-meshheading:16359516-Cardiovascular Diseases,
pubmed-meshheading:16359516-Collagen,
pubmed-meshheading:16359516-Cyclooxygenase 1,
pubmed-meshheading:16359516-Dose-Response Relationship, Drug,
pubmed-meshheading:16359516-Drug Resistance,
pubmed-meshheading:16359516-Female,
pubmed-meshheading:16359516-Humans,
pubmed-meshheading:16359516-Male,
pubmed-meshheading:16359516-Middle Aged,
pubmed-meshheading:16359516-Platelet Aggregation,
pubmed-meshheading:16359516-Thromboxane A2
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.
|
|
pubmed:affiliation |
Department of Experimental Medicine and Pathology, University La Sapienza, Roma 00161, Italy. fabio.pulcinelli@uniroma1.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
